Journal of Social & Health Sciences,
Journal Year:
2023,
Volume and Issue:
2, P. 5 - 16
Published: Dec. 31, 2023
Alzheimer's
disease
(AD)
is
increasingly
prevalent,
especially
among
African
American
older
adults.
Despite
its
widespread
nature,
accurate
and
timely
diagnosis
of
AD
remains
challenging.
Addressing
the
research
gap
in
sociodemographic
cardiovascular
risk
factor
associated
with
adults,
this
study
aimed
to
identify
analyze
distinct
subgroups
within
population
that
are
particularly
vulnerable
AD,
thereby
contributing
development
targeted
interventions
healthcare
strategies.
This
employs
a
rigorous
methodology
utilizing
classification
regression
tree
(CART)
analysis
examine
data
from
2017
Uniform
Data
Set
(UDS).
approach
enables
nuanced
susceptibility
The
CART
revealed
significant
associations
between
studied
factors
results
indicate
presence
specific
increased
vulnerability
shaped
by
varying
levels
education
[relative
importance
(RI):
100%],
antidepressant
usage
(RI:
83.1%),
BMI
71.2%),
use
antipsychotic
agents
35.5%),
age
smoking
cessation
21.5%).
These
findings
underscore
culturally
for
addressing
Americans.
study's
findings,
revealing
necessity
developing
policies
specifically
tailored
address
these
risks.
Progress in Retinal and Eye Research,
Journal Year:
2024,
Volume and Issue:
101, P. 101273 - 101273
Published: May 15, 2024
The
retina
is
an
emerging
CNS
target
for
potential
noninvasive
diagnosis
and
tracking
of
Alzheimer's
disease
(AD).
Studies
have
identified
the
pathological
hallmarks
AD,
including
amyloid
β-protein
(Aβ)
deposits
abnormal
tau
protein
isoforms,
in
retinas
AD
patients
animal
models.
Moreover,
structural
functional
vascular
abnormalities
such
as
reduced
blood
flow,
Aβ
deposition,
blood-retinal
barrier
damage,
along
with
inflammation
neurodegeneration,
been
described
mild
cognitive
impairment
dementia.
Histological,
biochemical,
clinical
studies
demonstrated
that
nature
severity
pathologies
brain
correspond.
Proteomics
analysis
revealed
a
similar
pattern
dysregulated
proteins
biological
pathways
patients,
enhanced
inflammatory
neurodegenerative
processes,
impaired
oxidative-phosphorylation,
mitochondrial
dysfunction.
Notably,
investigational
imaging
technologies
can
now
detect
AD-specific
deposits,
well
vasculopathy
neurodegeneration
living
suggesting
alterations
at
different
stages
links
to
pathology.
Current
exploratory
ophthalmic
modalities,
optical
coherence
tomography
(OCT),
OCT-angiography,
confocal
scanning
laser
ophthalmoscopy,
hyperspectral
imaging,
may
offer
promise
assessment
AD.
However,
further
research
needed
deepen
our
understanding
AD's
impact
on
its
progression.
To
advance
this
field,
future
require
replication
larger
diverse
cohorts
confirmed
biomarkers
standardized
retinal
techniques.
This
will
validate
aiding
early
screening
monitoring.
Journal Of Clinical Periodontology,
Journal Year:
2023,
Volume and Issue:
50(11), P. 1444 - 1454
Published: Aug. 16, 2023
Abstract
Aim
To
assess
whether
periodontitis
is
associated
with
cognitive
decline
and
its
progression
as
well
certain
blood‐based
markers
of
Alzheimer's
disease.
Materials
Methods
Data
from
a
2‐year
follow‐up
prospective
cohort
study
(
n
=
101)
was
analysed.
Participants
previous
history
hypertension
aged
≥60
years
were
included
in
the
analysis.
All
them
received
full‐mouth
periodontal
examination
function
assessments
(Addenbrooke's
Cognitive
Examination
(ACE)
Mini‐Mental
State
[MMSE]).
Plasma
levels
amyloid
beta
(Aβ)
1‐40
,
Aβ
1‐42
phosphorylated
total
Tau
(p‐Tau
t‐Tau)
determined
at
baseline,
12
24
months.
Results
Periodontitis
poor
performance
(MMSE:
β
−1.5
[0.6])
impairment
(hazard
ratio
[HR]
1.8;
95%
confidence
interval:
1.0–3.1).
Subjects
showed
greater
baseline
p‐Tau
(1.6
[0.7]
vs.
1.2
[0.2]
pg/mL,
p
<
.001)
(242.1
[77.3]
208.2
[73.8]
.036)
compared
those
without
periodontitis.
Concentrations
latter
protein
also
increased
over
time
only
group
.005).
Conclusions
elderly
patients
hypertension.
Overexpression
may
play
role
this
association.
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Dec. 7, 2023
This
study
aimed
to
investigate
the
relationship
between
hypertension
and
Alzheimer's
disease
(AD)
demonstrate
key
role
of
stroke
in
this
using
mediating
Mendelian
randomization.
AD,
a
neurodegenerative
characterized
by
memory
loss,
cognitive
impairment,
behavioral
abnormalities,
severely
affects
quality
life
patients.
Hypertension
is
an
important
risk
factor
for
AD.
However,
precise
mechanism
underlying
unclear.
To
we
used
mediated
randomization
method
screened
variables
AD
setting
instrumental
variables.
The
results
analysis
showed
that
stroke,
as
variable,
plays
causal
Specifically,
indirect
effect
value
obtained
multivariate
MR
was
54.9%.
implies
approximately
55%
owing
can
be
attributed
stroke.
suggest
increased
through
finding
not
only
sheds
light
on
but
also
indicates
novel
methods
prevention
treatment
By
identifying
critical
link
provides
insights
into
potential
interventions
could
mitigate
impact
help
develop
personalized
treatments
improve
patients
with
who
suffer
from
hypertension.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 2363 - 2363
Published: March 6, 2025
Alzheimer's
disease
is
a
progressive
neurodegenerative
disorder
with
limited
treatment
options.
Lingonberry
(Vaccinium
vitis-idaea
L.)
has
demonstrated
neuroprotective
and
anti-inflammatory
properties,
yet
the
underlying
mechanisms
remain
unclear.
This
study
employed
network
pharmacology,
molecular
docking,
dynamics
simulations
to
explore
therapeutic
potential
in
disease.
Pathway
analysis
identified
monoamine
oxidase
B
as
key
target
involved
serotonergic
synapse
dysfunction
related
Molecular
docking
revealed
that
ferulic
acid,
major
bioactive
compound
lingonberry,
exhibits
strong
binding
affinity
B.
Further
confirmed
stability
of
this
interaction,
highlighting
inhibitory
effect
acid
on
These
findings
provide
novel
insights
into
lingonberry
suggest
its
natural
intervention
for
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 28, 2025
Background
Alzheimer’s
disease
(AD)
is
a
neurodegenerative
that
imposes
heavy
burden
on
patients
and
their
families.
Hypertension
an
important
risk
factor
for
AD,
but
the
specific
mechanism
of
its
impact
still
unclear.
This
study
thus
aimed
to
analyze
relationship
trend
changes
between
AD
hypertension
through
bibliometric
methods.
Methods
Literature
was
retrieved
from
Web
Science
Core
Collection
(WoSCC)
database
2004
2023.
Data
regarding
countries,
institutions,
authors
journals
were
sourced
WoSCC.
CiteSpace
VOSviewer
used
data
visualization,
including
author
collaboration,
timelines
view
references,
reference
bursts
overlay
visualization
maps
keywords.
Excel
2018
software
statistical
analysis.
Results
A
total
1,833
publications
ultimately
included.
From
2023,
number
per
year
basically
showed
increasing
trend.
The
United
States
(United
States)
not
only
had
largest
output
highest
H-index
also
seven
frequencies
publication
institutions.
Kehoe,
Patrick
ranked
first
with
most
articles
among
9,330
authors.
journal
published
Journal
Disease.
Reference
analysis
revealed
hotspot
in
exploration
pathophysiological
association
hypertension.
Second,
treatment
effects
potential
risks
antihypertensive
drugs
(AHDs)
are
focus
research.
Researchers
have
carried
out
series
studies
ranging
basic
research
clinical
AHDs
AD.
Finally,
personalized
strategies
will
become
one
hotspots
future
Controlling
lifestyle
medication
interventions
promising
strategy.
keywords
“amyloid
deposition,”
“preeclampsia,”
“Corona
Virus
Disease
2019
(COVID-19)”
“biomarkers”
been
recent
years.
Conclusion
By
analyzing
references
keywords,
we
summarized
hot
topics
trends
this
field.
These
findings
provide
useful
information
researchers
explore
further,
hope
providing
more
effective
treatments
delay
progression
improve
quality
life.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(13), P. 7084 - 7084
Published: June 27, 2024
Alzheimer's
disease
is
a
pathology
characterized
by
the
progressive
loss
of
neuronal
connections,
which
leads
to
gray
matter
atrophy
in
brain.
most
prevalent
type
dementia
and
has
been
classified
into
two
types,
early
onset,
associated
with
genetic
factors,
late
environmental
factors.
One
greatest
challenges
regarding
high
economic
cost
involved,
why
number
studies
aimed
at
prevention
treatment
have
increased.
possible
approach
use
resistance
exercise
training,
given
that
it
shown
neuroprotective
effects
disease,
such
as
increasing
cortical
hippocampal
volume,
improving
neuroplasticity,
promoting
cognitive
function
throughout
life
cycle.
However,
how
training
specifically
prevents
or
ameliorates
not
fully
characterized.
Therefore,
aim
this
review
was
identify
molecular
basis
could
prevent
treat
disease.
Cardiology in Review,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 23, 2024
Systemic
hypertension
is
possibly
the
most
important
modifiable
risk
factor
for
development
of
cognitive
decline,
both
mild
impairment
(MCI)
and
dementia.
For
effective
blood
pressure
(BP)
control,
it
requires
proper
assessment,
using
brachial,
central,
ambulatory
measurements,
monitoring
with
a
focus
on
different
BP
parameters.
Different
parameters
like
pulse
pressure,
mean
arterial
variability,
circadian
parameters,
nondippers
early
morning
surge,
should
be
considered
in
evaluation
decline
due
to
middle
age
older
adults.
Chronic
causes
vascular
remodeling
brain
leads
failure
or
decline.
Achieving
specific
goals
can
improve
clinical
outcomes
slow
down
patients
comorbid
impairment.
Noise and Health,
Journal Year:
2024,
Volume and Issue:
26(123), P. 445 - 448
Published: Oct. 1, 2024
Exposure
to
sound
energy
may
be
a
risk
factor
or
therapeutic
intervention
for
Alzheimer’s
disease
(AD).
On
one
hand,
noise
has
harmful
effect
on
people
with
AD
by
contributing
hearing
loss,
sleep
disturbance,
oxidative
stress,
inflammation,
and
excitotoxicity.
But
the
other
clinical
trials
nursing
home
interventions
soundscape
augmentation
involving
natural
sounds
have
shown
promising
results
in
alleviating
psychophysiological
symptoms
AD.
Music
therapy,
an
emerging
non-pharmacological
treatment,
can
improve
cognition,
reduce
anxiety
depression,
enhance
self-awareness
patients
To
ensure
that
music
does
not
become
trials,
only
favorite
at
levels
safe
should
used.
From
public
health
standpoint,
countermeasures,
sounds,
active
passive
engagement
regarded
as
potentially
powerful
strategies
prevention
of
Journal of Alzheimer s Disease,
Journal Year:
2023,
Volume and Issue:
96(4), P. 1529 - 1546
Published: Nov. 21, 2023
Background:
Blood
biomarkers
have
the
potential
to
transform
Alzheimer’s
disease
(AD)
diagnosis
and
monitoring,
yet
their
integration
with
common
medical
comorbidities
remains
insufficiently
explored.
Objective:
This
study
aims
enhance
blood
biomarkers’
sensitivity,
specificity,
predictive
performance
by
incorporating
comorbidities.
We
assess
this
integration’s
efficacy
in
diagnostic
classification
using
machine
learning,
hypothesizing
that
it
can
identify
a
confident
set
of
features.
Methods:
analyzed
data
from
1,705
participants
Health
Aging
Brain
Study-Health
Disparities,
including
116
AD
patients,
261
mild
cognitive
impairment,
1,328
cognitively
normal
controls.
samples
were
assayed
electrochemiluminescence
single
molecule
array
technology,
alongside
comorbidity
gathered
through
clinical
interviews
records.
visually
explored
biomarker
characteristics,
developed
Feature
Importance
SVM-based
Leave-One-Out
Recursive
Elimination
(FI-SVM-RFE-LOO)
method
optimize
feature
selection,
compared
four
models:
Biomarker
Only,
Comorbidity
Comorbidity,
Feature-Selected
Comorbidity.
Results:
The
combination
model
17
12
variables
outperformed
single-modal
models,
NPV12
at
92.78%,
AUC
67.59%,
Sensitivity
65.70%.
selection
led
22
chosen
features,
resulting
highest
performance,
93.76%,
69.22%,
70.69%.
Additionally,
interpretative
learning
highlighted
factors
contributing
improved
prediction
performance.
Conclusions:
In
conclusion,
combining
feature-selected
enhances
while
optimizes
integration.
These
findings
hold
promise
for
understanding
pathophysiology
advancing
preventive
treatments.